医学
猴痘
心包炎
心肌炎
疾病
爆发
流行病学
重症监护医学
克莱德
大流行
2019年冠状病毒病(COVID-19)
病毒学
心脏病学
内科学
传染病(医学专业)
化学
系统发育树
基因
生物化学
牛痘
重组DNA
作者
Guang-Gui Zeng,Wanli Jiang,Yu Jiang,Guiying Nie,Yanjiao Lu,C Xiao,Chuan Wang,Zheng Kang
标识
DOI:10.1016/j.cpcardiol.2023.102116
摘要
Mpox, a novel epidemic disease, has broken out the period of coronavirus disease 2019 since May 2022, which was caused by the mpox virus. Up to 12 September 2023, there are more than 90439 confirmed mpox cases in over 115 countries all over the world. Moreover, the outbreak of mpox in 2022 was verified to be Clade II rather than Clade I. Highlighting the significance of this finding, a growing body of literature suggests that mpox may lead to a series of cardiovascular complications, including myocarditis and pericarditis. It is indeed crucial to acquire more knowledge about mpox from a perspective from the clinical cardiologist. In this review, we would discuss the epidemiological characteristics and primary treatments of mpox to attempt to provide a framework for cardiovascular physicians.
科研通智能强力驱动
Strongly Powered by AbleSci AI